drugset / Trial / NCT02546570

Oxytocin and Affect Processing in Posttraumatic Stress Disorder

NCT02546570 ↗

Phase 2 Completed 11 enrolled Yale University National Center for PTSD · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators will use multiple methods (including Oxytocin intranasal inhalation, neuroimaging, behavioral measures, peripheral hormone measurements) to examine how individuals' behavior, cognition, and brain function is impacted by the neuro-hormone Oxytocin. Specifically, the investigators plan to evaluate the influence of Oxytocin administration on affective processing in non-trauma exposed and trauma-exposed adults (both with and without posttraumatic stress disorder, PTSD).

Timeline

Start
2015-08
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 24 iu Intranasal